Sacha E. Gandhi

Sacha E. Gandhi

Auto-generated profile, based on publicly available information

Sacha E. Gandhi

School of Neuroscience and Psychology, University of Glasgow, Glasgow, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2024 in Movement Disorders Clinical Practice
Verified
Journal Article
Closed access
SGSacha E. Gandhi
Sacha E. Gandhi
TZTanja Zerenner
Tanja Zerenner
ANAnahita Nodehi
Anahita Nodehi
MLMichael A. Lawton
Michael A. Lawton
VMVicky Marshall
Vicky Marshall
DGDonald G. Grosset
Donald G. Grosset

19 June 2024 in Movement Disorders Clinical Practice
Verified
Journal Article
Closed access
SGSacha E. Gandhi
Sacha E. Gandhi
ANAnahita Nodehi
Anahita Nodehi
MLMichael A. Lawton
Michael A. Lawton
KGKatherine A. Grosset
Katherine A. Grosset
VMVicky Marshall
Vicky Marshall
DGDonald G. Grosset
Donald G. Grosset

22 October 2025 in Movement Disorders Clinical Practice
Verified
Journal Article
Open access
SGSacha E. Gandhi
Sacha E. Gandhi
KGKatherine A. Grosset
Katherine A. Grosset
PIPrasanth A. Iruthayaraj
Prasanth A. Iruthayaraj
RGRomel Gravesande
Romel Gravesande
LLLance Lee
Lance Lee
DGDonald G. Grosset
Donald G. Grosset
Background: Findings are contradictory regarding changes in the incidence and prevalence of Parkinson's disease ( PD ) over time; data for other parkinsonian disorders are rare. Objectives: To analyze temporal trends in the incidence and prevalence of eight parkinsonisms (PD, MSA, PSP, CBS, DLB, vascular parkinsonism, drug‐induced parkinsonism, and other secondary parkinsonism) from 2003 to 2023, assess their survival, and define sociodemographic factors associated with PD. Methods: Analysis of primary and linked secondary care data in a population‐based UK observational study using multivariable regression models and Kaplan–Meier survival methods. Results: Age‐ and sex‐adjusted incidence and prevalence rates of rarer parkinsonisms increased substantially pre‐Covid‐19, while adjusted PD rates declined then stabilized. From 2003 to 2010, the incidence of rarer parkinsonisms increased annually by 13.8% (95% CI 13.5, 14.0%), while PD incidence declined annually by 4.7% (4.5, 4.9%). From 2011 to 2019, the incidence of rarer parkinsonisms increased annually by 3.2% (2.9, 3.5%) while PD incidence changed by −0.3% (−0.5, 0.0%) annually. Prevalence fell for PD from 2003 to 2019 by 0.6% annually (0.6, 0.7%), but increased for other parkinsonisms by 7.1% (6.8, 7.3%) before slowing to 3.3% (3.1, 3.5%) annually. Of the degenerative parkinsonisms, 5‐year survival was best for PD at 64.2% (64.0, 64.4%) and worst for PSP at 30.5% (29.3, 31.8%). Adjusted PD incidence was 43% lower (16, 62%) in individuals of African/Caribbean ethnicity, but similar for Asian and White ethnicities. Conclusions: Increasing diagnosis of rarer parkinsonisms has contributed to changing temporal trends for PD. Ethnic variations for PD justify further exploration.

15 August 2022 in Advances in Clinical Neuroscience & Rehabilitation
Verified
Journal Article
Open access
SGSacha E Gandhi
Sacha E Gandhi
DADavid G Anderson
David G Anderson
ENEdward J Newman
Edward J Newman
Dystonia is a hyperkinetic movement disorder (HMD), characterised by sustained or intermittent involuntary muscle contractions resulting in abnormal postures and/or movements [1]. Although primary dystonia has an estimated prevalence of 16 per 100,000 [2], the diagnosis may be delayed, due to its clinical heterogeneity, the lack of objective biomarkers and the potential for pseudodystonic conditions to mimic it [1,3]. We provide an overview of the classification and common subtypes of focal dystonia, focusing on the clinical phenomenology and diagnosis.

11 March 2026 in Journal of Parkinson’s Disease
Verified
Journal Article
Open access
SGSacha E Gandhi
Sacha E Gandhi
KGKatherine A Grosset
Katherine A Grosset
PIPrasanth A Iruthayaraj
Prasanth A Iruthayaraj
LLLance Lee
Lance Lee
CDCathal Doyle
Cathal Doyle
DGDonald G Grosset
Donald G Grosset
Background: Osteoporosis and major osteoporotic fracture are more common in PD than controls, but evaluation of sociodemographic factors and preventive treatment is limited. Methods: In a UK population-based nested case-control study, incidence rates of osteoporosis and major osteoporotic fracture were calculated, and risk factors and bone health treatments analyzed by multivariable regression. Results: Falls, osteoporosis and major osteoporotic fracture were more likely before a diagnosis of PD compared to controls ( P < 0.0001). After diagnosis, incident osteoporosis, HR 1.96 (1.90, 2.02) and incident fractures, HR 2.16 (2.11, 2.21) were more likely in PD than controls, both P < 0.005. Risks of fracture were increased in PD cases during 3 consecutive time periods post-diagnosis: 0–7 years, HR 2.15 (2.09, 2.21), 7–14 years, HR 2.36 (2.24, 2.48), and 14–21 years, HR 1.88 (1.62, 2.17), all P < 0.0001. Risks of osteoporosis and fracture increased with older age, female sex, greater deprivation and White ethnicity. In PD, anti-osteoporosis treatment was underutilized in men, OR 0.25 (0.24, 0.26) versus women, being lower than the relative risks of osteoporosis in men, HR 0.35 (0.32, 0.37) and fracture in men, HR 0.60 (0.57, 0.63). There was also underutilization of anti-osteoporosis treatment in the most deprived quintile, HR 0.85 (0.80, 0.90), despite significantly higher rates of osteoporosis, HR 1.14 (1.01, 1.28) and fracture, HR 1.17 (1.06, 1.30). Conclusion: The increased bone health risks at all stages including the prodrome, and across multiple risk categories, emphasizes the need for early bone health assessment and increased anti-osteoporosis treatment rates.

30 November 2022 in Practical Neurology
Verified
Journal Article
Closed access
PDF file
SGSacha E Gandhi
Sacha E Gandhi
NFNatasha E Fullerton
Natasha E Fullerton
JNJagdish Ramachandran Nair
Jagdish Ramachandran Nair
CGClaire Gall
Claire Gall
He was afebrile, alert and orientated, with normal observations and no meningism. Examination showed a right hemiparesis with a brisk right knee jerk, equivocal plantars and right-sided ataxia. Tone, sensation and cranial nerves were intact. Blood investigations showed an erythrocyte sedimentation rate (ESR) of 22 mm/1st hour, with an otherwise negative vasculitis screen.